|
Market Closed -
Nasdaq
08:00:00 10/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 169.32 USD | +1.46% |
|
-0.59% | +37.95% |
| 10/11 | Daiwa Securities Adjusts Gilead Sciences Price Target to $174 From $150 | MT |
| 07/11 | Gilead Sciences Says Twice-Yearly Lenacapavir Shows Higher PrEP Persistence in Phase 2 Trial | MT |
| Market Cap | 210B 187B 172B 157B 297B 19,685B 304B 2,063B 822B 10,539B 788B 771B 33,193B | P/E 2026 * |
-39.7x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 231B 206B 190B 172B 326B 21,658B 335B 2,270B 905B 11,595B 867B 849B 36,519B | EV / Sales 2026 * |
7.37x | EV / Sales 2027 * | 6.6x |
| Free-Float |
99.89% | Yield 2026 * |
1.95% | Yield 2027 * | 1.99% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
| GILD | Real-time | ||
| GILD * | End-of-day quote | ||
| GIS | Real-time | ||
| GIS | Delayed | ||
| GIS | Delayed | ||
| GIS | Real-time | ||
| 0QYQ | Delayed | ||
| GILD | End-of-day quote | ||
| Real-time | |||
| GIS | Delayed | ||
| 1GILD | End-of-day quote | ||
| GILD | Delayed | ||
| GILD | End-of-day quote | ||
| GILDUS | End-of-day quote | ||
| GILDCL | End-of-day quote | ||
| GILD | Delayed | ||
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +1.46% | ||
| 1 week | -0.59% | ||
| Current month | -0.80% | ||
| 1 month | +12.01% | ||
| 3 months | +27.11% | ||
| 6 months | +28.93% | ||
| Current year | +37.95% |
| 1 week | 164 | 176.58 | |
| 1 month | 147.26 | 176.58 | |
| Current year | 116.88 | 176.58 | |
| 1 year | 116.88 | 176.58 | |
| 3 years | 62.07 | 176.58 | |
| 5 years | 57.16 | 176.58 | |
| 10 years | 56.56 | 176.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/11/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 15/10/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 15/10/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.46% | -0.59% | +42.48% | +125.82% | 207B | ||
| +4.28% | +0.07% | +52.75% | +138.78% | 1,206B | ||
| +2.13% | +4.27% | +51.21% | +91.36% | 665B | ||
| +0.68% | +1.54% | +33.83% | +112.47% | 515B | ||
| +2.77% | +0.98% | +49.44% | +68.46% | 381B | ||
| +1.38% | +0.27% | +72.42% | +45.30% | 362B | ||
| +0.29% | +1.48% | +30.84% | +58.32% | 307B | ||
| +0.98% | +1.49% | +9.04% | +34.78% | 289B | ||
| +1.04% | -0.05% | +45.29% | +76.18% | 249B | ||
| +1.24% | +0.96% | -6.32% | -60.78% | 177B | ||
| Average | +1.66% | +0.45% | +38.10% | +69.07% | 436B | |
| Weighted average by Cap. | +2.25% | +0.67% | +43.87% | +89.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 31.36B 27.99B 25.76B 23.38B 44.31B 2,940B 45.41B 308B 123B 1,574B 118B 115B 4,957B | 33.58B 29.97B 27.58B 25.03B 47.43B 3,147B 48.61B 330B 131B 1,685B 126B 123B 5,307B |
| Net income | -5.29B -4.72B -4.35B -3.94B -7.48B -496B -7.66B -51.99B -20.72B -266B -19.86B -19.44B -836B | 10.7B 9.55B 8.79B 7.97B 15.11B 1,003B 15.49B 105B 41.89B 537B 40.15B 39.29B 1,691B |
| Net Debt | 21.05B 18.79B 17.29B 15.69B 29.73B 1,973B 30.47B 207B 82.42B 1,056B 79B 77.31B 3,326B | 11.61B 10.36B 9.54B 8.66B 16.4B 1,088B 16.81B 114B 45.47B 583B 43.58B 42.65B 1,835B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | USD 169.32 | +1.46% | 4,470,450 |
| 06/11/26 | USD 166.89 | -0.41% | 5,817,788 |
| 05/11/26 | USD 167.57 | -3.96% | 11,355,969 |
| 04/11/26 | USD 174.48 | +4.19% | 9,636,516 |
| 03/11/26 | USD 167.47 | -1.68% | 6,606,702 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions

















